UNLABELLED: Previous studies demonstrated that targeted deletion of the Ron receptor tyrosine kinase (TK) domain in mice leads to marked hepatocyte protection in a well-characterized model of lipopolysaccharide (LPS)-induced acute liver failure in D-galactosamine (GalN)-sensitized mice. Hepatocyte protection in TK-/- mice was observed despite paradoxically elevated serum levels of tumor necrosis factor alpha (TNF-α). To understand the role of Ron in the liver, purified populations of Kupffer cells and hepatocytes from wildtype (TK+/+) and TK-/- mice were studied. Utilizing quantitative reverse-transcription polymerase chain reaction (RT-PCR), we demonstrated that Ron is expressed in these cell types. Moreover, we also recapitulated the protected hepatocyte phenotype and exaggerated cytokine production observed in the TK-/- mice in vivo through the use of purified cultured cells ex vivo. We show that isolated TK-/- Kupffer cells produce increased levels of TNF-α and select cytokines compared to TK+/+ cells following LPS stimulation. We also show that conditioned media from LPS-treated TK-/- Kupffer cells was more toxic to hepatocytes than control media, suggesting the exaggerated levels of cytokines produced from the TK-/- Kupffer cells are detrimental to wildtype hepatocytes. In addition, we observed that TK-/- hepatocytes were more resistant to cell death compared to TK+/+ hepatocytes, suggesting that Ron functions in both the epithelial and inflammatory cell compartments to regulate acute liver injury. These findings were confirmed in vivo in mice with hepatocyte and macrophage cell-type-specific conditional Ron deletions. Mice with Ron loss selectively in hepatocytes exhibited less liver damage and increased survival compared to mice with Ron loss in macrophages. CONCLUSION: We dissected cell-type-specific roles for Ron such that this receptor modulates cytokine production from Kupffer cells and inhibits hepatocyte survival in response to injury.
UNLABELLED: Previous studies demonstrated that targeted deletion of the Ronreceptor tyrosine kinase (TK) domain in mice leads to marked hepatocyte protection in a well-characterized model of lipopolysaccharide (LPS)-induced acute liver failure in D-galactosamine (GalN)-sensitized mice. Hepatocyte protection in TK-/- mice was observed despite paradoxically elevated serum levels of tumor necrosis factor alpha (TNF-α). To understand the role of Ron in the liver, purified populations of Kupffer cells and hepatocytes from wildtype (TK+/+) and TK-/- mice were studied. Utilizing quantitative reverse-transcription polymerase chain reaction (RT-PCR), we demonstrated that Ron is expressed in these cell types. Moreover, we also recapitulated the protected hepatocyte phenotype and exaggerated cytokine production observed in the TK-/- mice in vivo through the use of purified cultured cells ex vivo. We show that isolated TK-/- Kupffer cells produce increased levels of TNF-α and select cytokines compared to TK+/+ cells following LPS stimulation. We also show that conditioned media from LPS-treated TK-/- Kupffer cells was more toxic to hepatocytes than control media, suggesting the exaggerated levels of cytokines produced from the TK-/- Kupffer cells are detrimental to wildtype hepatocytes. In addition, we observed that TK-/- hepatocytes were more resistant to cell death compared to TK+/+ hepatocytes, suggesting that Ron functions in both the epithelial and inflammatory cell compartments to regulate acute liver injury. These findings were confirmed in vivo in mice with hepatocyte and macrophage cell-type-specific conditional Ron deletions. Mice with Ron loss selectively in hepatocytes exhibited less liver damage and increased survival compared to mice with Ron loss in macrophages. CONCLUSION: We dissected cell-type-specific roles for Ron such that this receptor modulates cytokine production from Kupffer cells and inhibits hepatocyte survival in response to injury.
Authors: Nikolaos M Nikolaidis; Rishikesh M Kulkarni; Jerilyn K Gray; Margaret H Collins; Susan E Waltz Journal: Innate Immun Date: 2010-11-18 Impact factor: 2.680
Authors: Alex B Lentsch; Peterson Pathrose; Sarah Kader; Satoshi Kuboki; Margaret H Collins; Susan E Waltz Journal: Shock Date: 2007-03 Impact factor: 3.454
Authors: Charles C Caldwell; Andre Martignoni; Mike A Leonis; Hari Kumar Ondiveeran; Alison E Fox-Robichaud; Susan E Waltz Journal: Crit Care Med Date: 2008-05 Impact factor: 7.598
Authors: Tom Luedde; Jan Heinrichsdorff; Rossana de Lorenzi; Rita De Vos; Tania Roskams; Manolis Pasparakis Journal: Proc Natl Acad Sci U S A Date: 2008-07-07 Impact factor: 11.205
Authors: Nikolaos M Nikolaidis; Jerilyn K Gray; Devikala Gurusamy; William Fox; William D Stuart; Nathan Huber; Susan E Waltz Journal: Shock Date: 2010-02 Impact factor: 3.454
Authors: William D Stuart; Nicholas E Brown; Andrew M Paluch; Susan E Waltz Journal: Am J Physiol Endocrinol Metab Date: 2015-02-03 Impact factor: 4.310
Authors: Purnima K Wagh; Glendon M Zinser; Jerilyn K Gray; Archana Shrestha; Susan E Waltz Journal: Endocrinology Date: 2012-04-02 Impact factor: 4.736
Authors: Rishikesh M Kulkarni; Louis W Kutcher; William D Stuart; Daniel J Carson; Mike A Leonis; Susan E Waltz Journal: Hepatobiliary Pancreat Dis Int Date: 2012-08-15
Authors: Devikala Gurusamy; Jerilyn K Gray; Peterson Pathrose; Rishikesh M Kulkarni; Fred D Finkleman; Susan E Waltz Journal: Cancer Res Date: 2013-01-17 Impact factor: 12.701
Authors: Rishikesh M Kulkarni; William D Stuart; Devikala Gurusamy; Susan E Waltz Journal: Am J Physiol Gastrointest Liver Physiol Date: 2014-04-17 Impact factor: 4.052